ocrelizumab
roche
['ease', 'ocrevus', 'multiple sclerosis']
ocrevus safely and effectively reduces disease activity in people with early-stage relapsing-remitting multiple sclerosis, trial data show. #multiplesclerosis #msnews #msawareness #msresearch 
We exist to bring you science, research and clinical news about MS. We are a free digital publication dedicated to the patient community.